logo
Select company
Select metric
$ -28.01MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
18
Sector
44
Industry
60
History
75
$ 1.65Close
$ 1.06 - $ 4.46 52-Week Range
Ticker Information

Ticker

MGNX

Company Name

MACROGENICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MACROGENICS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MGNX - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 6.47M$ -34.48M$ -28.01M
3/31/2025$ 6.59M$ -54.8M$ -48.21M
12/31/2024$ 6.88M$ -64.91M$ -58.03M
9/30/2024$ 10.01M$ -96.48M$ -86.47M
6/30/2024$ 10.38M$ -135.23M$ -124.85M
3/31/2024$ 11.67M$ -21.33M$ -9.66M
12/31/2023$ 13.13M$ -7.63M$ 5.51M
9/30/2023$ 13.68M$ 51.25M$ 64.92M
6/30/2023$ 13.7M$ 8.88M$ 22.58M
3/31/2023$ 12.88M$ -90.67M$ -77.79M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MACROGENICS INC's latest trailing twelve months (TTM) EBITDA stands at $ -146.25M.
  • Over the past 5 years, MACROGENICS INC's average EBITDA has been $ -93.61M.
  • The median EBITDA for MACROGENICS INC during this period was $ -112.84M
  • MACROGENICS INC reached its highest EBITDA over the past 5 years at $ 64.92M.
  • The lowest EBITDA recorded by MACROGENICS INC in the same timeframe $ -207.12M

MACROGENICS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
CHRS : COHERUS ONCOLOGY INC $ 200.92MIGMS : IGM BIOSCIENCES INC $ -41.96MATRA : ATARA BIOTHERAPEUTICS INC $ 24.86MSTRO : SUTRO BIOPHARMA INC $ -169.79MAGEN : AGENUS INC $ -69.99MCELU : CELULARITY INC $ -58.15MCSBR : CHAMPIONS ONCOLOGY INC $ 4.42MIVVD : INVIVYD INC $ -106.81MPLX : PROTALIX BIOTHERAPEUTICS INC $ 10.55MBDTX : BLACK DIAMOND THERAPEUTICS INC $ 14.78M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for MACROGENICS INC is calculated as follows: EBIT [ $ -158.05M ] + DepAmor [ $ 11.79M ]
(=) EBITDA [ $ -146.25M ]

MGNX - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -207.12M

Minimum

Jun 30, 2022

$ 64.92M

Maximum

Sep 30, 2023

$ -93.61M

Average

$ -112.84M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M